Literature DB >> 24806302

Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy.

Olga Tarabal1, Víctor Caraballo-Miralles, Andrea Cardona-Rossinyol, Francisco J Correa, Gabriel Olmos, Jerònia Lladó, Josep E Esquerda, Jordi Calderó.   

Abstract

Motoneuron (MN) cell death is the histopathologic hallmark of spinal muscular atrophy (SMA), although MN loss seems to be a late event. Conversely, disruption of afferent synapses on MNs has been shown to occur early in SMA. Using a mouse model of severe SMA (SMNΔ7), we examined the mechanisms involved in impairment of central synapses. We found that MNs underwent progressive degeneration in the course of SMA, with MN loss still occurring at late stages. Loss of afferent inputs to SMA MNs was detected at embryonic stages, long before MN death. Reactive microgliosis and astrogliosis were present in the spinal cord of diseased animals after the onset of MN loss. Ultrastructural observations indicate that dendrites and microglia phagocytose adjacent degenerating presynaptic terminals. Neuronal nitric oxide synthase was upregulated in SMNΔ7 MNs, and there was an increase in phosphorylated myosin light chain expression in synaptic afferents on MNs; these observations implicate nitric oxide in MN deafferentation and suggest that the RhoA/ROCK pathway is activated. Together, our observations suggest that the earliest change occurring in SMNΔ7 mice is the loss of excitatory glutamatergic synaptic inputs to MNs; reduced excitability may enhance their vulnerability to degeneration and death.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806302     DOI: 10.1097/NEN.0000000000000074

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  23 in total

Review 1.  Developing therapies for spinal muscular atrophy.

Authors:  Mary H Wertz; Mustafa Sahin
Journal:  Ann N Y Acad Sci       Date:  2015-07-14       Impact factor: 5.691

Review 2.  Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Authors:  Chiara Simone; Agnese Ramirez; Monica Bucchia; Paola Rinchetti; Hardy Rideout; Dimitra Papadimitriou; Diane B Re; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2015-12-18       Impact factor: 9.261

3.  Astrocytes influence the severity of spinal muscular atrophy.

Authors:  Hansjörg Rindt; Zhihua Feng; Chiara Mazzasette; Jacqueline J Glascock; David Valdivia; Noah Pyles; Thomas O Crawford; Kathryn J Swoboda; Teresa N Patitucci; Allison D Ebert; Charlotte J Sumner; Chien-Ping Ko; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2015-04-24       Impact factor: 6.150

4.  Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy.

Authors:  Clàudia Cerveró; Neus Montull; Olga Tarabal; Lídia Piedrafita; Josep E Esquerda; Jordi Calderó
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 5.  Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.

Authors:  Natalia N Singh; Shaine Hoffman; Prabhakara P Reddi; Ravindra N Singh
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-05       Impact factor: 5.187

Review 6.  Spinal muscular atrophy: from tissue specificity to therapeutic strategies.

Authors:  Daniel M Iascone; Christopher E Henderson; Justin C Lee
Journal:  F1000Prime Rep       Date:  2015-01-05

7.  Decreased microRNA levels lead to deleterious increases in neuronal M2 muscarinic receptors in Spinal Muscular Atrophy models.

Authors:  Patrick J O'Hern; Inês do Carmo G Gonçalves; Johanna Brecht; Eduardo Javier López Soto; Jonah Simon; Natalie Chapkis; Diane Lipscombe; Min Jeong Kye; Anne C Hart
Journal:  Elife       Date:  2017-05-02       Impact factor: 8.140

8.  New insights into SMA pathogenesis: immune dysfunction and neuroinflammation.

Authors:  Marc-Olivier Deguise; Rashmi Kothary
Journal:  Ann Clin Transl Neurol       Date:  2017-05-18       Impact factor: 4.511

Review 9.  Functional Genomics of Axons and Synapses to Understand Neurodegenerative Diseases.

Authors:  Andres Di Paolo; Joaquin Garat; Guillermo Eastman; Joaquina Farias; Federico Dajas-Bailador; Pablo Smircich; José Roberto Sotelo-Silveira
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

Review 10.  ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets.

Authors:  Emmanuelle Coque; Cédric Raoul; Mélissa Bowerman
Journal:  Front Neurosci       Date:  2014-08-28       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.